R. Rodríguez-Vélez, “Exposure to Non-Therapeutic INR in a High Risk Cardiovascular Patient: Potential Hazard Reduction with Genotype-guided Warfarin (Coumadin®) Dosing”, PRHSJ, vol. 29, no. 4, Nov. 2010.